Forehead Temperature-Regulating Therapy for Tourette's Disorder (TD)

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles, CA
Tourette's Disorder (TD)+3 More
Forehead Temperature-Regulating Therapy - Device
Eligibility
18 - 65
All Sexes
What conditions do you have?
Select

Study Summary

The primary aim of the present research project is to investigate the preliminary effects of four weeks of forehead temperature-regulating therapy on insomnia in adults with Tourette's disorder and co-occurring insomnia disorder. This project will also examine the effects of the device on depression, anxiety, and daytime sleepiness, and explore its effects on tic severity.

Eligible Conditions

  • Tourette's Disorder (TD)
  • Insomnia

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Tourette's Disorder (TD)

Study Objectives

2 Primary · 3 Secondary · Reporting Duration: 5 weeks

5 weeks
Actigraphy - Sleep Onset Latency
Actigraphy - Wake After Sleep Onset
Depression Anxiety Stress Scale (DASS)-21 - Anxiety
Depression Anxiety Stress Scale (DASS)-21 - Depression
Epworth Sleepiness Scale (ESS)
Yale Global Tic Severity Scale (YGTSS) - Total Tic Severity Score

Trial Safety

Safety Progress

1 of 3

Other trials for Tourette's Disorder (TD)

Trial Design

1 Treatment Group

Forehead Temperature-Regulating Therapy
1 of 1
Experimental Treatment

25 Total Participants · 1 Treatment Group

Primary Treatment: Forehead Temperature-Regulating Therapy · No Placebo Group · N/A

Forehead Temperature-Regulating Therapy
Device
Experimental Group · 1 Intervention: Forehead Temperature-Regulating Therapy · Intervention Types: Device

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 5 weeks

Trial Background

Prof. Emily J. Ricketts, PhD
Principal Investigator
University of California, Los Angeles
Closest Location: Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles · Los Angeles, CA
Photo of Los Angeles  1Photo of Los Angeles  2Photo of Los Angeles  3
N/AFirst Recorded Clinical Trial
2 TrialsResearching Tourette's Disorder (TD)
0 CompletedClinical Trials

Eligibility Criteria

Age 18 - 65 · All Participants · 7 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have Tourette's disorder.
You have a sleep efficiency of less than 85 per cent on at least 50 per cent of nights over a week.
You are fluent in English.\n
You have a diagnosis of insomnia disorder.
You have Tourette's disorder or persistent motor tic disorder or persistent vocal tic disorder.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.